We use cookies for a better user experience. Read our Privacy Policy

I Agree

Physician Dispensed Cosmeceuticals Market

Physician Dispensed Cosmeceuticals Market (Product Type: Face-care and Skincare; and Application: Skin Lightening or De-pigmenting, Rhytide Reduction, Anti-wrinkle/Aging, Scar-reducing, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Physician Dispensed Cosmeceuticals Market Outlook 2031

  • The global physician dispensed cosmeceuticals market was valued at US$ 8.5 Bn in 2020
  • It is estimated to expand at a CAGR of 7.8% from 2021 to 2031
  • The global physician dispensed cosmeceuticals market is expected to reach the value of US$ 19 Bn by the end of 2031

Analysts’ Viewpoint on Physician Dispensed Cosmeceuticals Market Scenario

The physician dispensed cosmeceuticals market is likely to witness steady expansion driven by the increase in demand for products and better resolution of supply chain issues in various countries amid the COVID-19 outbreak. Brands in the physician dispensed cosmeceuticals market are under scrutiny for possible side effects and adverse events through the usage of products. Hence, brands should increase awareness about the doctor and physician’s consultation through advertising & marketing for physician dispensed cosmeceutical products. Companies are striving to innovate in dermatologically-approved skincare cosmeceuticals to meet the demand for aging population. Women’s education and penetration of smartphones in rural and remote regions of Asia Pacific such as in India, Sri Lanka, and Bangladesh is helping for increased product uptake.

Social Media Important Tool for Brand Awareness of Cosmeceuticals

The growing awareness about facial beauty enhancement is contributing to the expansion of the physician dispensed cosmeceuticals market. An Increasing number of smartphone users are consuming social media to gain awareness about new brands in the physician dispensed cosmeceuticals market. The burgeoning growth of the online influencer community on social media is emerging as an important strategy for brand building.

Apart from branding, communication about natural ingredients in physician dispensed cosmeceuticals is helping to boost product uptake. Such trends are contributing to the expansion of the global physician dispensed cosmeceuticals market. Recycled bottles and cruelty-free products are being preferred by customers.

Request a sample to get extensive insights into the Physician Dispensed Cosmeceuticals Market

Re-evaluation of Supply Networks Helps Ensure Timely Deliveries amid COVID-19 Outbreak

Burgeoning growth of the eCommerce industry and growing adoption of online shopping apps have made it easier for customers to order products by sitting in the convenience of their homes during the COVID-19 outbreak. Such findings are triggering the expansion of the physician dispensed cosmeceuticals market. However, brands need to address poor market sentiments, since the demand for cosmeceuticals is surging slowly owing to slow movements of goods. Nevertheless, brands and manufacturing are rethinking their supply networks to avoid disruptions in product deliveries.

Import and export of physician dispensed cosmeceuticals are projected to rise due to increase in shipment and demand for products.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Can Customer Reviews Hamper Sales of Physician Dispensed Cosmeceuticals?

Although social media and eCommerce are playing an instrumental role in brand building, negative reviews and low ratings for products tend to affect sales of physician dispensed cosmeceuticals. In a quest to establish transparency and authenticity for facial and skincare cosmeceuticals, brands tend to lose credibility due to unhappy or unsatisfied customers. Hence, brands are developing websites and online portals where they can regulate the comments or reviews posted by consumers.

Brands on popular eCommerce platforms are operating with the mindset of high risk-high reward to make their products available in the public eye. They are developing mobile apps to meet personalized needs of customers and enable repeat purchase of facial and skincare cosmeceuticals. Brands are working closely with physicians to develop mobile apps that offer a personalized experience to customers.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Physician Dispensed Cosmeceuticals Market

Accessibility for Cosmeceuticals Achieved with Education and Advertising

Companies in the physician dispensed cosmeceuticals market are increasing the availability of products that offer both cosmetic and therapeutic benefits to consumers. Increase in consciousness and concerns about stressful lifestyle, aging, and harmful effects of pollution & damage to skin & face due to UV rays are key indicators that are projected to drive the expansion of the global physician dispensed cosmeceuticals market throughout the assessment tenure.

In addition, rising awareness about personal maintenance among the geriatric population and changing attitudes of middle aged population in developing countries are propelling the demand for cosmeceuticals for eliminating the outward aging signs. Women's education in remote and rural regions of Asia Pacific has improved access to advertisements, smartphones, newspapers, and magazines that tend to impart preliminary knowledge to judge genuine and efficacious cosmeceuticals.

Physician Dispensed Face-care Products Help Eliminate Chemical Ingredients

The high prevalence of acne, scars, and pigmentation among men and women is translating into value-grab opportunities for participants in the market. There is a growing demand for scar-reducing cosmeceuticals that enable skin lightening, rhytide reduction, and anti aging. Increase in usage of physician prescribed scar reduction products to clean and treat various scars is contributing toward market expansion.

The demand for physician dispensed face-care products has increased, since most of the people are seeking physician’s or doctor’s consultation to treat various facial conditions in order to reduce the use of chemicals ingredients that can aggravate the facial conditions.

Physician Dispensed Cosmeceuticals Market: Overview

  • According to Transparency Market Research’s latest report on the global physician dispensed cosmeceuticals market for the historical period 2017–2019 and forecast period 2021–2031, increase in consciousness and concerns about aging, harmful effects of pollution & damage to skin & face due to UV rays, and stressful lifestyle are projected to drive the global physician dispensed cosmeceuticals market during the forecast period

Increase in Consumer Consciousness and Awareness: Key Driver

  • Rise in consciousness about personal maintenance among the geriatric population and changing attitudes of middle aged & aging population in developing countries propel the demand for cosmeceuticals for eliminating the outward aging signs
  • Moreover, increase in awareness about cosmeceuticals among most of the upper- and middle-class women and men in developed countries augments the global physician dispensed cosmeceuticals market. Women's education in underdeveloped regions has improved access to newspapers, magazines, and advertisements that tend to impart preliminary knowledge to judge genuine and effective cosmeceuticals.

Entry of Dermatologists and Product Developers to Boost Market Growth

  • Dermatologists have started developing cosmeceuticals alongside their skincare clinics and centers. Dermatologists and skincare specialists are opening their individual startups with locally manufactured low-cost products developed by their own clinics. This trend has led to the entry of new players in developing markets in Asia Pacific. Various cosmetic professional companies specialized in manufacturing and marketing cosmeceuticals are being owned by dermatologists who have recently entered the global physician dispensed cosmeceutical market, such as ZO Skin Health, Inc.

Consumer Apprehensions on Potential Side Effects of Cosmeceuticals to Hamper Market Growth

  • Consumers in developing and underdeveloped regions are relatively less aware about the advanced and innovative cosmeceuticals in the market. They lack knowledge about product results and the high cost of physician consultation and cosmeceutical products. This acts as a barrier to usage of cosmeceuticals.

Physician Dispensed Cosmeceuticals Market: Competition Landscape

  • This report profiles major players in the global physician dispensed cosmeceuticals market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global physician dispensed cosmeceuticals market is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global physician dispensed cosmeceuticals market are
    • AbbVie Inc. (Allergan)
    • L'Oreal S.A.
    • Jan Marini Skin Research, Inc.
    • Athena Cosmetics, Inc.
    • ZO Skin Health Inc.
    • Galderma Laboratories, L.P.
    • Procter & Gamble Co.
    • The Estée Lauder Companies, Inc.
    • Merz Pharma
    • Obagi Cosmeceuticals LLC
    • iS CLINICAL
    • Neutrogena
    • Velius, LLC
    • Sonoma Pharmaceuticals, Inc.
    • Sientra, Inc.
    • Dynamic Techno Medicals
    • Implantech Associates, Inc.
    • CCA Industries, Inc., and among others

Physician Dispensed Cosmeceuticals Market: Key Developments

  • Key players in the global physician dispensed cosmeceuticals market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global physician dispensed cosmeceuticals market. A few expansion strategies adopted by players operating in the global physician dispensed cosmeceuticals market are:
    • In April 2021, Neutrogena's 'People with Skin' campaign is part of its long-term commitment to improving skin health for all. The company is committed to improving skin health in the U.S. through advocacy, education, expertise, and transparency through this program.
    • In April 2019, Merz Pharma, a global leader in medical aesthetics, announced the launch of Belotero Revive, a dermal filler product containing a unique combination of HA and glycerol that is intended to improve skin hydration, elasticity, and firmness, while addressing the appearance of fine lines and wrinkles.
  • The report on the physician dispensed cosmeceuticals market discusses individual strategies, followed by company profiles of manufacturers of physician dispensed cosmeceuticals. The competition landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global physician dispensed cosmeceuticals market.

Physician Dispensed Cosmeceuticals Market Snapshot

Attribute

Detail

Market Size Value in 2020

US$ 8.5 Bn

Market Forecast Value in 2031

US$ 19 Bn

Growth Rate (CAGR)

7.8%

Forecast Period

2021–2031

Quantitative Units

US$ Bn for Value

Market Analysis

It includes cross segment analysis at global as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Market share analysis by company (2020)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Product Type
    • Face-care
    • Skincare
  • Indication
    • Skin Lightening or De-pigmenting
    • Rhytide Reduction
    • Anti-Wrinkle/Aging
    • Scar-reducing
    • Others

Regions Covered

  • North America
  • Latin America
  • Europe
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • AbbVie, Inc. (Allergan)
  • L'Oreal S.A.
  • Jan Marini Skin Research, Inc.
  • Athena Cosmetics, Inc.
  • ZO Skin Health, Inc.
  • Galderma Laboratories, L.P.
  • Procter & Gamble Co.
  • The Estée Lauder Companies, Inc.
  • Merz Pharma
  • Obagi Cosmeceuticals LLC
  • iS CLINICAL
  • Neutrogena
  • Velius, LLC
  • Sonoma Pharmaceuticals, Inc.
  • Sientra, Inc.
  • Dynamic Techno Medicals
  • Implantech Associates, Inc.
  • CCA Industries, Inc.

Customization Scope

Available upon request

Pricing

Available upon request

Physician Dispensed Cosmeceuticals Market – Segmentation

Product Type
  • Face-care
  • Skincare
Application
  • Skin Lightening or De-pigmenting
  • Rhytide Reduction
  • Anti-wrinkle / Aging
  • Scar-reducing
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Interested in this report?
Get a FREE sample now!

Get Free Sample

*Get Sample Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of physician dispensed cosmeceuticals market?

Physician dispensed cosmeceuticals market is expected to reach the value of US$ 19 Bn by the end of 2031

What is the anticipated CAGR of the physician dispensed cosmeceuticals market in the forecast period?

Physician dispensed cosmeceuticals market is estimated to expand at a CAGR of 7.8% from 2021 to 2031

What are the key driving factors for the growth of the physician dispensed cosmeceuticals market?

Physician dispensed cosmeceuticals market is driven by increase in awareness about cosmeceuticals among most of the upper- and middle-class women and men in developed countries

Which region is expected to project the highest market share in the global physician dispensed cosmeceuticals market?

North America accounted for a major share of the global physician dispensed cosmeceuticals market

Who are the key players in the global physician dispensed cosmeceuticals market?

Key players in the global physician dispensed cosmeceuticals market include AbbVie, Inc. (Allergan), L'Oreal S.A., Jan Marini Skin Research, Inc., Athena Cosmetics, Inc., ZO Skin Health, Inc

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Physician Dispensed Cosmeceuticals Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Type Definition

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Physician Dispensed Cosmeceuticals Market Analysis and Forecast, 2017–2031

5. Key Insights

    5.1. Product/ Brand Analysis

    5.2. Key Mergers & Acquisitions

    5.3. Regulatory Scenario by Region/globally

    5.4. COVID-19 Pandemics Impact on Industry (value chain and short / mid / long term impact)

6. Global Physician Dispensed Cosmeceuticals Market Analysis and Forecast, by Product Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Product Type, 2017–2031

        6.3.1. Face-care

        6.3.2. Skincare

    6.4. Market Attractiveness Analysis, by Product Type

7. Global Physician Dispensed Cosmeceuticals Market Analysis and Forecast, by Indication

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Indication, 2017–2031

        7.3.1. Skin Lightening or De-pigmenting

        7.3.2. Rhytide Reduction

        7.3.3. Anti-wrinkle/Aging

        7.3.4. Scar-reducing

        7.3.5. Others

    7.4. Market Attractiveness Analysis, by Indication

8. Global Physician Dispensed Cosmeceuticals Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Market Value Forecast, by Region

        8.2.1. North America

        8.2.2. Europe

        8.2.3. Asia Pacific

        8.2.4. Latin America

        8.2.5. Middle East & Africa

    8.3. Market Attractiveness Analysis, by Region

9. North America Physician Dispensed Cosmeceuticals Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Market Value Forecast, by Product Type, 2017–2031

        9.2.1. Face-care

        9.2.2. Skincare

    9.3. Market Value Forecast, by Indication, 2017–2031

        9.3.1. Skin Lightening or De-pigmenting

        9.3.2. Rhytide Reduction

        9.3.3. Anti-wrinkle/Aging

        9.3.4. Scar-reducing

        9.3.5. Others

    9.4. Market Value Forecast, by Country, 2017–2031

        9.4.1. U.S.

        9.4.2. Canada

    9.5. Market Attractiveness Analysis

        9.5.1. By Product Type

        9.5.2. By Indication

        9.5.3. By Country

10. Europe Physician Dispensed Cosmeceuticals Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Product Type, 2017–2031

        10.2.1. Face-care

        10.2.2. Skincare

    10.3. Market Value Forecast, by Indication, 2017–2031

        10.3.1. Skin Lightening or De-pigmenting

        10.3.2. Rhytide Reduction

        10.3.3. Anti-wrinkle/Aging

        10.3.4. Scar-reducing

        10.3.5. Others

    10.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        10.4.1. Germany

        10.4.2. U.K.

        10.4.3. France

        10.4.4. Italy

        10.4.5. Spain

        10.4.6. Rest of Europe

    10.5. Market Attractiveness Analysis

        10.5.1. By Product Type

        10.5.2. By Indication

        10.5.3. By Country/Sub-region

11. Asia Pacific Physician Dispensed Cosmeceuticals Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Product Type, 2017–2031

        11.2.1. Face-care

        11.2.2. Skincare

    11.3. Market Value Forecast, by Indication, 2017–2031

        11.3.1. Skin Lightening or De-pigmenting

        11.3.2. Rhytide Reduction

        11.3.3. Anti-wrinkle/Aging

        11.3.4. Scar-reducing

        11.3.5. Others

    11.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        11.4.1. China

        11.4.2. Japan

        11.4.3. India

        11.4.4. Australia & New Zealand

        11.4.5. Rest of Asia Pacific

    11.5. Market Attractiveness Analysis

        11.5.1. By Product Type

        11.5.2. By Indication

        11.5.3. By Country/Sub-region

12. Latin America Physician Dispensed Cosmeceuticals Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Product Type, 2017–2031

        12.2.1. Face-care

        12.2.2. Skincare

    12.3. Market Value Forecast, by Indication, 2017–2031

        12.3.1. Skin Lightening or De-pigmenting

        12.3.2. Rhytide Reduction

        12.3.3. Anti-wrinkle/Aging

        12.3.4. Scar-reducing

        12.3.5. Others

    12.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.4.1. Brazil

        12.4.2. Mexico

        12.4.3. Rest of Latin America

    12.5. Market Attractiveness Analysis

        12.5.1. By Product Type

        12.5.2. By Indication

        12.5.3. By Country/Sub-region

13. Middle East & Africa Physician Dispensed Cosmeceuticals Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Product Type, 2017–2031

        13.2.1. Face-care

        13.2.2. Skincare

    13.3. Market Value Forecast, by Indication, 2017–2031

        13.3.1. Skin Lightening or De-pigmenting

        13.3.2. Rhytide Reduction

        13.3.3. Anti-wrinkle/Aging

        13.3.4. Scar-reducing

        13.3.5. Others

    13.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.4.1. GCC Countries

        13.4.2. South Africa

        13.4.3. Rest of Middle East & Africa

    13.5. Market Attractiveness Analysis

        13.5.1. By Product Type

        13.5.2. By Indication

        13.5.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player - Competition Matrix (by tier and size of companies)

    14.2. Company Profiles

        14.2.1. AbbVie Inc. (Allergan)

            14.2.1.1. Company Overview

            14.2.1.2. Financial Overview

            14.2.1.3. Product Portfolio

            14.2.1.4. SWOT Analysis

            14.2.1.5. Strategic Overview

        14.2.2. L'Oreal S.A.

            14.2.2.1. Company Overview

            14.2.2.2. Financial Overview

            14.2.2.3. Product Portfolio

            14.2.2.4. SWOT Analysis

            14.2.2.5. Strategic Overview

        14.2.3. Jan Marini Skin Research, Inc.

            14.2.3.1. Company Overview

            14.2.3.2. Financial Overview

            14.2.3.3. Product Portfolio

            14.2.3.4. SWOT Analysis

            14.2.3.5. Strategic Overview

        14.2.4. Athena Cosmetics, Inc.

            14.2.4.1. Company Overview

            14.2.4.2. Financial Overview

            14.2.4.3. Product Portfolio

            14.2.4.4. SWOT Analysis

            14.2.4.5. Strategic Overview

        14.2.5. ZO Skin Health Inc.

            14.2.5.1. Company Overview

            14.2.5.2. Financial Overview

            14.2.5.3. Product Portfolio

            14.2.5.4. SWOT Analysis

            14.2.5.5. Strategic Overview

        14.2.6. Galderma Laboratories, L.P.

            14.2.6.1. Company Overview

            14.2.6.2. Financial Overview

            14.2.6.3. Product Portfolio

            14.2.6.4. SWOT Analysis

            14.2.6.5. Strategic Overview

        14.2.7. Procter & Gamble Co.

            14.2.7.1. Company Overview

            14.2.7.2. Financial Overview

            14.2.7.3. Product Portfolio

            14.2.7.4. SWOT Analysis

            14.2.7.5. Strategic Overview

        14.2.8. The Estée Lauder Companies, Inc.

            14.2.8.1. Company Overview

            14.2.8.2. Financial Overview

            14.2.8.3. Product Portfolio

            14.2.8.4. SWOT Analysis

            14.2.8.5. Strategic Overview

        14.2.9. Merz Pharma

            14.2.9.1. Company Overview

            14.2.9.2. Financial Overview

            14.2.9.3. Product Portfolio

            14.2.9.4. SWOT Analysis

            14.2.9.5. Strategic Overview

        14.2.10. Obagi Cosmeceuticals LLC

            14.2.10.1. Company Overview

            14.2.10.2. Financial Overview

            14.2.10.3. Product Portfolio

            14.2.10.4. SWOT Analysis

            14.2.10.5. Strategic Overview

        14.2.11. iS CLINICAL

            14.2.11.1. Company Overview

            14.2.11.2. Financial Overview

            14.2.11.3. Product Portfolio

            14.2.11.4. SWOT Analysis

            14.2.11.5. Strategic Overview

        14.2.12. Neutrogena

            14.2.12.1. Company Overview

            14.2.12.2. Financial Overview

            14.2.12.3. Product Portfolio

            14.2.12.4. SWOT Analysis

            14.2.12.5. Strategic Overview

List of Tables

Table 01: Global Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Product Type 2017–2031

Table 02: Global Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Indication, 2017‒2031

Table 03: Global Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 04: North America Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 05: North America Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 06: North America Physician Dispensed Cosmeceuticals Market (US$ Mn) Forecast, by Indication, 2017–2031

Table 07: Europe Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 08: Europe Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 09: Europe Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 10: Asia Pacific Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 11: Asia Pacific Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 12: Asia Pacific Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 13: Latin America Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 14: Latin America Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 15: Asia Pacific Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 16: Middle East & Africa Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 17: Middle East & Africa Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 18: Middle East & Africa Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Indication, 2017–2031

List of Figures

Figure 01: Global Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Physician Dispensed Cosmeceuticals Market Value Share, by Product Type, 2020

Figure 03: Global Physician Dispensed Cosmeceuticals Market Value Share, by Indication, 2020

Figure 04: Global Physician Dispensed Cosmeceuticals Market Value Share, by Region, 2020

Figure 05: Global Physician Dispensed Cosmeceuticals Market, by Product Type, 2020 and 2031

Figure 06: Global Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 07: Global Physician Dispensed Cosmeceuticals Market (US$ Mn), by Face-care, 2017–2031

Figure 08: Global Physician Dispensed Cosmeceuticals Market (US$ Mn), by Skincare, 2017–2031

Figure 09: Global Physician Dispensed Cosmeceuticals Market, by Indication, 2020 and 2031

Figure 10: Global Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Indication, 2021–2031

Figure 11: Global Physician Dispensed Cosmeceuticals Market (US$ Mn), by Skin Lightening or De-pigmenting, 2017–2031

Figure 12: Global Physician Dispensed Cosmeceuticals Market (US$ Mn), by Rhytide Reduction, 2017–2031

Figure 13: Global Physician Dispensed Cosmeceuticals Market (US$ Mn), by Anti-wrinkle/Aging, 2017–2031

Figure 14: Global Physician Dispensed Cosmeceuticals Market (US$ Mn), by Scar-reducing, 2017–2031

Figure 15: Global Physician Dispensed Cosmeceuticals Market (US$ Mn), by Others, 2017–2031

Figure 16: Global Physician Dispensed Cosmeceuticals Market Value Share Analysis, by Region, 2020 and 2031

Figure 17: Global Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Region, 2021–2031

Figure 18: North America Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, 2017–2031

Figure 19: North America Physician Dispensed Cosmeceuticals Market Value Share Analysis, by Country, 2020 and 2031

Figure 20: North America Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Country, 2021–2031 

Figure 21: North America Physician Dispensed Cosmeceuticals Market, by Product Type, 2020 and 2031

Figure 22: North America Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 23: North America Physician Dispensed Cosmeceuticals Market, by Indication, 2020 and 2031

Figure 24: North America Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Indication, 2021–2031

Figure 25: Europe Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, 2017–2031

Figure 26: Europe Physician Dispensed Cosmeceuticals Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031

Figure 27: Europe Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 28: Europe Physician Dispensed Cosmeceuticals Market, by Product Type, 2020 and 2031

Figure 29: Europe Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 30: Europe Physician Dispensed Cosmeceuticals Market, by Indication, 2020 and 2031

Figure 31: Europe Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Indication, 2021–2031

Figure 32: Asia Pacific Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, 2017–2031

Figure 33: Asia Pacific Physician Dispensed Cosmeceuticals Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031

Figure 34: Asia Pacific Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 35: Asia Pacific Physician Dispensed Cosmeceuticals Market, by Indication, 2020 and 2031

Figure 36: Asia Pacific Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Indication, 2021–2031

Figure 37: Latin America Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, 2017–2031

Figure 38: Latin America Physician Dispensed Cosmeceuticals Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031

Figure 39: Latin America Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 40: Latin America Physician Dispensed Cosmeceuticals Market, by Product Type, 2020 and 2031

Figure 41: Latin America Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 42: Latin America Physician Dispensed Cosmeceuticals Market, by Indication, 2020 and 2031

Figure 43: Latin America Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Indication, 2021–2031

Figure 44: Middle East & Africa Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, 2017–2031

Figure 45: Middle East & Africa Physician Dispensed Cosmeceuticals Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031

Figure 46: Middle East & Africa Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 47: Middle East & Africa Physician Dispensed Cosmeceuticals Market, by Product Type, 2020 and 2031

Figure 48: Middle East & Africa Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 49: Middle East & Africa Physician Dispensed Cosmeceuticals Market, by Indication, 2020 and 2031

Figure 50: Middle East & Africa Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Indication, 2021–2031

Transparency Market Research Plus

Get a free copy if the report you purchased is updated within 90 days

Copyright © Transparency Market Research, Inc. All Rights reserved